UBS Group AG Discloses 3.0% Passive Stake in Sight Sciences
Ticker: UBS · Form: SC 13G · Filed: Feb 7, 2024 · CIK: 1610520
| Field | Detail |
|---|---|
| Company | Ubs Group Ag (UBS) |
| Form Type | SC 13G |
| Filed Date | Feb 7, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-investment, SC-13G
TL;DR
**UBS Group AG just revealed a 3.0% passive stake in Sight Sciences.**
AI Summary
UBS Group AG, a major Swiss financial services company, reported on February 7, 2024, that it holds 1,600,000 shares of Sight Sciences, Inc. common stock, representing 3.0% of the company's outstanding shares. This position was established as of December 29, 2023. While UBS Group AG is a significant institutional investor, its 3.0% stake is below the 5% threshold that would typically signal a more aggressive, activist investment, indicating a passive holding. This matters to investors because it shows a large, sophisticated institution has a notable, albeit passive, interest in Sight Sciences, Inc., potentially lending some credibility to the stock.
Why It Matters
This filing reveals a major financial institution, UBS Group AG, has taken a significant, though passive, stake in Sight Sciences, Inc., which could be seen as a vote of confidence in the company's future.
Risk Assessment
Risk Level: low — This filing indicates a passive investment by a large institution, which generally carries lower risk than an activist stake.
Analyst Insight
Investors should note that a large institution like UBS Group AG has a stake, but given it's a passive 3.0% holding, it's unlikely to drive immediate significant stock movements. It's a data point for long-term confidence rather than a short-term catalyst.
Key Numbers
- 1,600,000 — Shares Beneficially Owned (Represents the total number of Sight Sciences, Inc. shares held by UBS Group AG.)
- 3.0% — Percentage of Class (Indicates the proportion of Sight Sciences, Inc.'s outstanding common stock owned by UBS Group AG.)
Key Players & Entities
- UBS Group AG (company) — reporting person, major financial institution
- Sight Sciences, Inc. (company) — subject company, issuer of securities
- 1,600,000 (dollar_amount) — number of shares beneficially owned by UBS Group AG
- 3.0% (dollar_amount) — percentage of class beneficially owned by UBS Group AG
- December 29, 2023 (person) — date of event requiring the filing
Forward-Looking Statements
- UBS Group AG will maintain a passive investment in Sight Sciences, Inc. below the 5% threshold. (UBS Group AG) — high confidence, target: Next 12 months
FAQ
What is the specific percentage of Sight Sciences, Inc. common stock beneficially owned by UBS Group AG, according to this filing?
UBS Group AG beneficially owns 3.0% of the Common Stock, par value $0.001 per share, of Sight Sciences, Inc., as stated in the filing.
When was the 'Date of Event Which Requires Filing of this Statement' for this SC 13G?
The 'Date of Event Which Requires Filing of this Statement' was December 29, 2023, as indicated in the filing.
Under which specific rule of the Securities Exchange Act of 1934 was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), as marked with an 'X' in the filing.
What is the CUSIP Number for the class of securities reported in this filing?
The CUSIP Number for the Common Stock, par value $0.001 per share, of Sight Sciences, Inc. is 82657M105, according to the filing.
What is the total number of shares of Common Stock of Sight Sciences, Inc. that UBS Group AG directly and on behalf of certain subsidiaries beneficially owns?
UBS Group AG directly and on behalf of certain subsidiaries beneficially owns 1,600,000 shares of Common Stock of Sight Sciences, Inc., as reported in the filing.
Filing Details
This Form SC 13G (Form SC 13G) was filed with the SEC on February 7, 2024 by December 29, 2023 regarding UBS Group AG (UBS).